Molecular Changes in Pre-Metastatic Lymph Nodes of Esophageal Cancer Patients
Open Access
- 21 July 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (7) , e102552
Abstract
Lymph node metastasis indicates poor prognosis in esophageal cancer. To understand the underlying mechanisms, most studies so far focused on investigating the tumors themselves and/or invaded lymph nodes. However they neglected the potential events within the metastatic niche, which precede invasion. Here we report the first description of these regulations in patients on transcription level. We determined transcriptomic profiles of still metastasis-free regional lymph nodes for two patient groups: patients classified as pN1 (n = 9, metastatic nodes exist) or pN0 (n = 5, no metastatic nodes exist). All investigated lymph nodes, also those from pN1 patients, were still metastasis-free. The results show that regional lymph nodes of pN1 patients differ decisively from those of pN0 patients – even before metastasis has taken place. In the pN0 group distinct immune response patterns were observed. In contrast, lymph nodes of the pN1 group exhibited a clear profile of reduced immune response and reduced proliferation, but increased apoptosis, enhanced hypoplasia and morphological conversion processes. DKK1 was the most significant gene associated with the molecular mechanisms taking place in lymph nodes of patients suffering from metastasis (pN1). We assume that the two molecular profiles observed constitute different stages of a progressive disease. Finally we suggest that DKK1 might play an important role within the mechanisms leading to lymph node metastasis.Keywords
This publication has 58 references indexed in Scilit:
- DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathwayMolecular Cancer, 2013
- PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodesProceedings of the National Academy of Sciences, 2013
- Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expressionJournal of Experimental Medicine, 2012
- Genome-Wide Screening for Genetic Alterations in Esophageal Cancer by aCGH Identifies 11q13 Amplification Oncogenes Associated with Nodal MetastasisPLOS ONE, 2012
- Therapeutic targets for bone metastases in breast cancerBreast Cancer Research, 2011
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaBlood, 2009
- Regulation of T‐cell immunity by leucocyte immunoglobulin‐like receptors: innate immune receptors for self on antigen‐presenting cellsImmunology, 2009
- The role of Dickkopf-1 in bone development, homeostasis, and diseaseBlood, 2009
- Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myelomaBlood, 2007
- The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer typesBritish Journal of Cancer, 2007